The D16 Participant Biography Booklet
Total Page:16
File Type:pdf, Size:1020Kb
EXECUTIVE INNOVATION LAB ON DIABETES AND OBESITY PARTICIPANT BIOGRAPHIES d16 PARTICIPANTS JENNIFER AAKER BECKY BAUSMAN A social psychologist, Becky is a C-level advisor Jennifer Aaker is the and marketing strategy General Atlantic Professor consultant at Cunningham of Marketing at Stanford Collective, an innovation-to- University’s Graduate market consulting firm School of Business. Her based in San Francisco. research focuses on the psychology of time, money Becky’s marketing leadership career is rooted in and happiness—specifically how people chose to technology and the product marketing discipline, spend their time and money, and when and why built on 18 years with enterprises spanning those choices are associated with lasting value. hardware and professional services. She is above all Aaker teaches courses at Stanford’s Graduate a positioner, writer, and framer, deft at organizing School of Business and Hasso Plattner Institute of complex ideas and conveying them in relatable Design (“d.school”) such as “Building Innovative ways. As a principal at Cunningham Collective, she Brands” (with Chris Flink, IDEO), The Innovation shapes marketing, positioning, and go-to-market Playbook, Designing Story in a Digital World, and strategies for companies in hardware, SaaS, travel, Rethinking Purpose. and health care sectors. [email protected] @aaker [email protected] @BeckyOnTheRoad JOHN AGOS SAVI BAVEJA John is the Sr. Director and Savi has deep experience as the head of the a senior leader in the Cardiovascular and Diabetes management consulting advocacy team for the industry. He has consulted Partners in Patient Health on several iconic and group at Sanofi. He is successful transformations accountable for partnerships with cardiovascular in the technology industry and has previously and diabetes associations, provider and payers served on the Bain & Company Board. Prior to groups, along with diabetes patient groups and joining Bain, Savi obtained an MBA with high health advocates, working to address issues critical distinction as a Baker Scholar from Harvard to improving patient health. University and a BS with distinction as a Terman Scholar in Electrical Engineering from Stanford [email protected] @jjagos University. [email protected] D16: EXECUTIVE INNOVATION LAB ON DIABETES AND OBESITY | 1 ADAM BROWN PAUL CIECHANOWSKI Adam Brown has worked at Close Dr. Ciechanowski, MD, MPH, is Concerns since 2010. He is founder and CMO of Samepage currently the head of diabetes Health, a company providing technology and digital health, software and services for bringing nearly 15 years of addressing care of patients with personal experience with type 1 diabetes, depression and other diabetes to all of his work. Adam chronic conditions. Samepage has been highly involved in the expansion of technology Health’s platform provides collaborative care and coverage at Close Concerns, which includes glucose behavior change interventions for healthcare systems, meters, CGMs, insulin pumps, automated insulin delivery, payers and pharma/device companies. Dr. CIechanowski diabetes software, mobile apps, and wearables. Adam has dedicated his career to improving healthcare also serves as a senior editor and regular contributor at communication based on his blended background as a diaTribe.org, where he writes an acclaimed column family doctor, diabetes management specialist, and (Adam’s Corner) focused on actionable tips for living well psychiatrist. He has conducted national research and with diabetes. published extensively in top medical journals including JAMA, New England Journal of Medicine and others. He [email protected] @asbrown1 is an international authority on case management programs, behavior change, treatment adherence, and KELLY BROWNELL patient-provider communication. Kelly Brownell is Dean of the [email protected] @samepaging Sanford School of Public Policy at Duke University, where he is KELLY CLOSE also Robert L. Flowers Professor of Public Policy and Professor Kelly Close founded Close of Psychology and Concerns in 2002, a healthcare Neuroscience. Prior to joining the information company focused faculty at Duke, Brownell was at Yale University where he exclusively on diabetes and was the James Rowland Angell Professor of Psychology, obesity. Kelly’s passion for the Professor of Epidemiology and Public Health, and field comes from her extensive Director of the Rudd Center for Food Policy and professional work as well as from Obesity. her personal experience, having had diabetes for nearly 30 years. Kelly is founder and Chair of The diaTribe [email protected] @DukeSanford Foundation, a nonprofit established in 2012 to improve the lives of people with diabetes and pre-diabetes and to CURTIS CARTER advocate for action. Before starting Close Concerns and the diaTribe Foundation, Kelly’s work focused on life Curtis is the Director of Advocacy sciences more broadly; over nearly a dozen years, she at AstraZeneca (AZ), the seventh worked on Wall Street and at McKinsey & Company. Kelly largest pharmaceutical company has a BA from Amherst College and an MBA from in the world. Previous to his Harvard Business School. position at AZ, he was the [email protected] @kellyclose Director of Advocacy at Bristol- Myers Squibb and the Associate Director of Advocacy and Education at Amylin Pharmaceuticals for over a decade before they were acquired by AZ. [email protected] @AstraZeneca 2 | D16: EXECUTIVE INNOVATION LAB ON DIABETES AND OBESITY ANDY CUNNINGHAM SEAN DUFFY Andrea Cunningham is a strategic Sean Duffy is the co-founder marketing and communications and CEO of Omada Health, a expert who helped launch the digital behavioral medicine Apple Macintosh in 1984 as a part company dedicated to of Regis McKenna. She founded inspiring and empowering and is currently the president of people everywhere to live Cunningham Collective, Inc., an free of chronic conditions like heart disease and type innovation-to-market management consulting firm. 2 diabetes. In 2015, Omada was named one of Fast [email protected] @andycunningham4 Company’s “50 Most Innovative Companies in the ABDALLAH DAAR World.” Prior to Omada, Sean worked at both Google and IDEO. A former MD/MBA candidate at Harvard, Dr. Daar is Professor of Clinical he holds a BS in neuroscience from Columbia Public Health; Global Health; and University. Surgery. He is a member of the UN Secretary General’s Scientific [email protected] @seanduffy Advisory Board and Chair of the Scientific Advisory Board of Grand ESTHER DYSON Challenges Canada. He was the founding Chair of the Global Alliance for Chronic Diseases Esther Dyson is the founder and is a member of the board of the World Diabetes of HICCup (Health Initiative Foundation. Coordinating Council) and its [email protected] @AbdallahDaar 10-year project to create health (not care), the Way to DAVE DEBRONKART Wellville. The Wellville Accelerator operates in five small communities Dave deBronkart is a passionate around the US (see ww.hiccup.co). Previously, Dyson evangelist for transforming the published Release 1.0 and hosted PC Forum, the patient’s role in health and care, especially as enabled by the leading newsletter and conference of the emerging internet, health data and e-health infotech market, from 1982 to 2007. She currently tools. In 2007, he beat Stage IV spends 100 percent of her time on Wellville and kidney cancer by coupling great devotes the remaining 50 percent to angel medical care with a great online community of patient investments and board duties for companies peers. He now evangelizes for medicine to recognize the including 23andMe, Meetup and Voxiva. validity of activated, autonomous, empowered patients and to enable them in full partnerships and with full access [email protected] @edyson to their data. Dave was diagnosed with pre-diabetes in November 2014, and has since become involved with the YMCA Diabetes Prevention Program and a daily jogger. An accomplished international keynote speaker, Dave seeks to activate and align consumer, community health workers, and patient advocacy organizations in the US. His TED talk “Let Patients Help” is approaching a half million views and has been translated into 26 languages. [email protected] @ePatientDave D16: EXECUTIVE INNOVATION LAB ON DIABETES AND OBESITY | 3 WILL FLEISSIG PHIL GILBERT SR. Will Fleissig is the President and Phil Gilbert is the General CEO of Waterfront Toronto, the Manager of IBM Design, publicly-funded corporation which was formed in 2012 charged with the revitalization of and is focused on simplifying 2,000 industrial acres access to IBM’s capabilities. immediately adjacent to downtown Toronto – one of the Phil joined IBM in 2010 via largest urban infill projects in the world. He melds the the acquisition of Lombardi Software where he was fields of real estate development, planning, urban design President. Leveraging this outsider’s perspective and environmental stewardship. His collaborative combined with a healthy respect for IBM’s design approach to development aligns citizens, civic leaders, heritage, he is leading this effort to create a public agencies, investors and property owners in sustainable, modern culture rooted in the principles common-purpose decision making. of human-centered design. [email protected] @WaterfrontTO [email protected] @philgilbertsr FAITH FOREMAN KEVIN L. HAGAN Faith Foreman, Dr. P.H., MPH, LVN, is the Assistant Director of Kevin is the CEO of the Houston Health